1. Home
  2. LUCD vs PLX Comparison

LUCD vs PLX Comparison

Compare LUCD & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

SELL

Current Price

$0.40

Market Cap

192.9M

Sector

Health Care

ML Signal

SELL

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

SELL

Current Price

$2.89

Market Cap

207.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LUCD
PLX
Founded
2018
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.9M
207.1M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
LUCD
PLX
Price
$0.40
$2.89
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$4.00
★ $12.00
AVG Volume (30 Days)
★ 7.8M
940.5K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 16.67
N/A
EPS
N/A
★ 0.31
Revenue
$4,346,000.00
★ $52,744,000.00
Revenue This Year
$34.40
$65.42
Revenue Next Year
$191.30
N/A
P/E Ratio
★ N/A
$9.77
Revenue Growth
★ 79.00
N/A
52 Week Low
$0.30
$1.65
52 Week High
$1.63
$3.19

Technical Indicators

Market Signals
Indicator
LUCD
PLX
Relative Strength Index (RSI) 39.70 55.28
Support Level $0.30 $2.54
Resistance Level $0.48 $3.19
Average True Range (ATR) 0.04 0.18
MACD 0.01 0.04
Stochastic Oscillator 8.03 60.14

Price Performance

Historical Comparison
LUCD
PLX

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: